Atypical central serous chorioretinopathy treated with intravitreal injection of bivacizumab – a case report

Authors

  • Manash Kumar Goswami Department of Ophthalmology, BIRDEM General Hospital, Dhaka

DOI:

https://doi.org/10.3329/imcj.v9i1.27639

Abstract

Central serous chorioretinopathy (CSCR) is common in adult male having sudden dimness of vision in one eye and typical pattern of leakage in fundus fluorescein angiography. Treatment of typical central serous chorioretinopathy is conservative and / or focal laser photocoagulation. But atypical central serous chorioretinopathy is uncommon having different patterns of clinical presentation and features in fundous fluorescein angiography. Treatment option of atypical central serous chorioretinopathy is not yet established. Here, we present a case of atypical central serous chorioretinopathy successfully treated with intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF, Bivacizumab).

Ibrahim Med. Coll. J. 2015; 9(1): 34-36

Downloads

Download data is not yet available.
Abstract
754
PDF
652

Author Biography

Manash Kumar Goswami, Department of Ophthalmology, BIRDEM General Hospital, Dhaka



Downloads

Published

2016-05-07

How to Cite

Goswami, M. K. (2016). Atypical central serous chorioretinopathy treated with intravitreal injection of bivacizumab – a case report. Ibrahim Medical College Journal, 9(1), 34–36. https://doi.org/10.3329/imcj.v9i1.27639

Issue

Section

Case Reports